8/14/2019

Regeneron's Eylea, or aflibercept, has received FDA approval for its prefilled syringe containing a single 2-mg dose, which needs less preparation than vials. The prefilled syringe, which is indicated as a treatment for four retinal conditions, could be available by year's end.

Related Summaries